
    
      The study will include 2000 volunteers, 1,000 of whom will be vaccinated intramuscularly with
      a single dose of allantoic split inactivated seasonal influenza vaccine.

      All participants will be observed for 6 months to evaluate the effectiveness of the vaccine.
    
  